Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

02/02/2026 03:00

Feb 2 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              397.04              374.56           490.00    
                   (+6.0 pct)          (-3.9 pct)       (+0.6 pct)  
  Operating           88.29               70.75            85.00    
                   (+24.8 pct)         (-51.1 pct)      (+42.3 pct) 
  Pretax              89.38               72.04            85.00    
                   (+24.1 pct)         (-51.1 pct)      (+43.3 pct) 
  Net                 68.95               56.59            67.00    
                   (+21.8 pct)         (-48.8 pct)      (+33.9 pct) 
  EPS Basic        146.75 yen          120.49 yen       142.62 yen  
  EPS Diluted      146.70 yen          120.42 yen                   
  Ann Div                               80.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           40.00 yen                   
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T